To further fund the research and innovation behind Nima, we have been awarded a fast track Small Business Innovation Research grant from the National Institutes of Health. The phase 1 funding amount released is more than $210,000, which will help fund our research and development of a handheld consumer gluten detector (Nima!), getting it into your hands faster.
The objective of this project is to develop and commercialize an economical, accurate, fast and portable device for gluten detection in foods, which can be readily used by consumers on a regular basis. It will provide gluten-sensitive consumers, parents of children with food sensitivities, health care providers, food manufacturers and restaurants with a means of testing foods to better ensure safety, thereby improving consumer health and quality of life. Ultimately, we plan to extend this platform to the detection of all major proteins.
The SBIR program is one of the largest sources of early-stage capital for innovative small companies in the United States. It allows U.S.-owned and operated small businesses to engage in federal research and development that has a strong potential for commercialization. A key objective of this work is “translating promising technologies to the private sector through strategic public and private partnerships, so that life-saving innovations reach consumer markets.”
The NIH SBIR program funds early stage small businesses that are seeking to commercialize innovative biomedical technologies. This competitive program helps small businesses participate in federal research and development, develop life-saving technologies and create jobs.
We’re working hard to bring Nima to you in its most accurate and accessible, and we can’t wait to enter phase 2 and take food transparency to the next level.